RHYTHM PHARMACEUTICALS, INC. short interest in 2026
In 2026, RHYTHM PHARMACEUTICALS, INC.'s disclosed short interest ran from 9.42% of shares outstanding on 15 Jan 2026 to 14.94% on 15 Sep 2026, a change of +5.52 percentage points. The year's high was 14.96% on 31 Aug 2026 and its low 9.02% on 13 Feb 2026, averaging 12.01% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 21.89 days on 31 Aug 2026. Full history: RHYTHM PHARMACEUTICALS, INC..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 9.42% (15 Jan 2026)
- End of year
- 14.94% (15 Sep 2026)
- Change
- +5.52 pp
- High
- 14.96% (31 Aug 2026)
- Low
- 9.02% (13 Feb 2026)
- Average
- 12.01%
- Highest days to cover
- 21.89 (31 Aug 2026)
- SEC filings marked
- 7
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 9.42% | 9.87 | results (8-K) |
| 30 Jan 2026 | 9.35% | 11.80 | |
| 13 Feb 2026 | 9.02% | 7.90 | |
| 27 Feb 2026 | 9.47% | 9.10 | 10-K filed, results (8-K) |
| 13 Mar 2026 | 9.79% | 7.59 | |
| 31 Mar 2026 | 11.43% | 5.93 | |
| 15 Apr 2026 | 11.73% | 12.81 | |
| 30 Apr 2026 | 12.07% | 14.55 | |
| 15 May 2026 | 12.09% | 8.28 | 10-Q filed, results (8-K) |
| 29 May 2026 | 11.54% | 14.78 | |
| 15 Jun 2026 | 11.68% | 11.58 | |
| 30 Jun 2026 | 14.10% | 7.57 | |
| 15 Jul 2026 | 13.97% | 13.74 | |
| 31 Jul 2026 | 13.78% | 16.17 | |
| 14 Aug 2026 | 14.75% | 12.24 | 10-Q filed, results (8-K) |
| 31 Aug 2026 | 14.96% | 21.89 | |
| 15 Sep 2026 | 14.94% | 20.06 |
See also: RHYTHM PHARMACEUTICALS, INC.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.